RUNX2 is highly expressed in pancreatic cancer, liver cancer, and other malignant tumor tissues; hence, the knockdown of RUNX2 expression can inhibit its malignant biological behavior in cell experiments [18, 19]. The gene discussed is RUNX2; the disease is liver cancer.